ICL Cash vs Total Current Liabilities Analysis

ICL Stock

USD 4.77 0.03 0.63%

ICL Israel financial indicator trend analysis is infinitely more than just investigating ICL Israel Chemicals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ICL Israel Chemicals is a good investment. Please check the relationship between ICL Israel Cash and its Total Current Liabilities accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

Cash vs Total Current Liabilities

Cash vs Total Current Liabilities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ICL Israel Chemicals Cash account and Total Current Liabilities. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between ICL Israel's Cash and Total Current Liabilities is 0.59. Overlapping area represents the amount of variation of Cash that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of ICL Israel Chemicals, assuming nothing else is changed. The correlation between historical values of ICL Israel's Cash and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash of ICL Israel Chemicals are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Cash i.e., ICL Israel's Cash and Total Current Liabilities go up and down completely randomly.

Correlation Coefficient

0.59

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Cash

Cash refers to the most liquid asset of ICL Israel Chemicals, which is listed under current asset account on ICL Israel Chemicals balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from ICL Israel customers. The amounts must be unrestricted with restricted cash listed in a different ICL Israel account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.

Total Current Liabilities

Total Current Liabilities is an item on ICL Israel balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of ICL Israel Chemicals are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most indicators from ICL Israel's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ICL Israel Chemicals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

Sales General And Administrative To Revenue is expected to rise to 0.08 this year, although the value of Selling General Administrative will most likely fall to about 379.1 M.

	2021	2022	2023	2024 (projected)
Interest Expense	216M	327M	176.7M	120.4M
Depreciation And Amortization	588M	713M	590.1M	371.6M

Interest Expense Depreciation And Amortization

ICL Israel fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt
Total Assets		0.7	0.61	0.95	0.92	0.93	0.55	0.77	0.95	0.56	0.96	0.41	0.64	0.88	0.96	0.45	0.4	0.34	0.76	0.86	0.42	0.09	0.89	0.64	0.85	0.56
Short Long Term Debt Total	0.7		0.59	0.69	0.36	0.66	0.98	0.3	0.61	0.03	0.77	0.37	0.06	0.48	0.69	0.12	0.24	-0.1	0.97	0.44	0.13	-0.06	0.94	0.24	0.4	0.57
Other Current Liab	0.61	0.59		0.58	0.45	0.75	0.54	0.43	0.51	0.21	0.68	-0.21	0.15	0.4	0.67	0.24	0.14	-0.25	0.6	0.35	0.46	0.66	0.64	0.61	0.33	0.23
Total Current Liabilities	0.95	0.69	0.58		0.84	0.85	0.54	0.71	0.95	0.59	0.89	0.37	0.66	0.86	0.95	0.46	0.39	0.35	0.71	0.83	0.39	0.07	0.88	0.65	0.85	0.69
Total Stockholder Equity	0.92	0.36	0.45	0.84		0.85	0.19	0.84	0.88	0.68	0.83	0.31	0.77	0.86	0.86	0.56	0.38	0.52	0.44	0.88	0.46	0.13	0.63	0.69	0.88	0.45
Property Plant And Equipment Net	0.93	0.66	0.75	0.85	0.85		0.55	0.73	0.84	0.39	0.98	0.26	0.44	0.68	0.88	0.45	0.33	0.15	0.71	0.67	0.35	0.36	0.82	0.65	0.64	0.54
Net Debt	0.55	0.98	0.54	0.54	0.19	0.55		0.16	0.45	-0.17	0.67	0.32	-0.16	0.29	0.54	0.03	0.18	-0.22	0.93	0.27	0.04	-0.06	0.85	0.09	0.2	0.53
Retained Earnings	0.77	0.3	0.43	0.71	0.84	0.73	0.16		0.74	0.77	0.7	0.25	0.65	0.71	0.71	0.73	0.8	0.5	0.37	0.74	0.38	0.29	0.53	0.89	0.73	0.36
Accounts Payable	0.95	0.61	0.51	0.95	0.88	0.84	0.45	0.74		0.65	0.88	0.46	0.71	0.91	0.93	0.36	0.4	0.35	0.68	0.86	0.41	0.06	0.84	0.65	0.88	0.5
Cash	0.56	0.03	0.21	0.59	0.68	0.39	-0.17	0.77	0.65		0.37	0.17	0.91	0.76	0.59	0.57	0.6	0.59	0.11	0.69	0.34	0.13	0.31	0.8	0.79	0.12
Non Current Assets Total	0.96	0.77	0.68	0.89	0.83	0.98	0.67	0.7	0.88	0.37		0.38	0.43	0.72	0.91	0.42	0.35	0.18	0.82	0.71	0.3	0.2	0.91	0.58	0.67	0.6
Non Currrent Assets Other	0.41	0.37	-0.21	0.37	0.31	0.26	0.32	0.25	0.46	0.17	0.38		0.31	0.38	0.28	0.02	0.27	0.47	0.45	0.39	-0.11	-0.52	0.45	-0.08	0.37	0.3
Cash And Short Term Investments	0.64	0.06	0.15	0.66	0.77	0.44	-0.16	0.65	0.71	0.91	0.43	0.31		0.84	0.65	0.49	0.33	0.72	0.14	0.77	0.32	-0.07	0.36	0.62	0.88	0.22
Net Receivables	0.88	0.48	0.4	0.86	0.86	0.68	0.29	0.71	0.91	0.76	0.72	0.38	0.84		0.87	0.34	0.39	0.47	0.57	0.94	0.52	-0.11	0.73	0.62	0.98	0.32
Good Will	0.96	0.69	0.67	0.95	0.86	0.88	0.54	0.71	0.93	0.59	0.91	0.28	0.65	0.87		0.49	0.34	0.26	0.73	0.84	0.43	0.16	0.87	0.69	0.84	0.53
Common Stock Total Equity	0.45	0.12	0.24	0.46	0.56	0.45	0.03	0.73	0.36	0.57	0.42	0.02	0.49	0.34	0.49		0.61	0.57	0.08	0.37	-0.05	0.29	0.23	0.72	0.42	0.48
Common Stock Shares Outstanding	0.4	0.24	0.14	0.39	0.38	0.33	0.18	0.8	0.4	0.6	0.35	0.27	0.33	0.39	0.34	0.61		0.41	0.28	0.4	0.08	0.12	0.35	0.69	0.4	0.23
Short Term Investments	0.34	-0.1	-0.25	0.35	0.52	0.15	-0.22	0.5	0.35	0.59	0.18	0.47	0.72	0.47	0.26	0.57	0.41		-0.07	0.49	-0.05	-0.38	0.09	0.29	0.59	0.33
Non Current Liabilities Total	0.76	0.97	0.6	0.71	0.44	0.71	0.93	0.37	0.68	0.11	0.82	0.45	0.14	0.57	0.73	0.08	0.28	-0.07		0.51	0.18	-0.07	0.96	0.27	0.47	0.46
Inventory	0.86	0.44	0.35	0.83	0.88	0.67	0.27	0.74	0.86	0.69	0.71	0.39	0.77	0.94	0.84	0.37	0.4	0.49	0.51		0.64	-0.13	0.68	0.59	0.97	0.36
Other Current Assets	0.42	0.13	0.46	0.39	0.46	0.35	0.04	0.38	0.41	0.34	0.3	-0.11	0.32	0.52	0.43	-0.05	0.08	-0.05	0.18	0.64		0.25	0.28	0.41	0.54	-0.11
Other Stockholder Equity	0.09	-0.06	0.66	0.07	0.13	0.36	-0.06	0.29	0.06	0.13	0.2	-0.52	-0.07	-0.11	0.16	0.29	0.12	-0.38	-0.07	-0.13	0.25		-0.02	0.58	-0.15	-0.1
Total Liab	0.89	0.94	0.64	0.88	0.63	0.82	0.85	0.53	0.84	0.31	0.91	0.45	0.36	0.73	0.87	0.23	0.35	0.09	0.96	0.68	0.28	-0.02		0.44	0.65	0.58
Property Plant And Equipment Gross	0.64	0.24	0.61	0.65	0.69	0.65	0.09	0.89	0.65	0.8	0.58	-0.08	0.62	0.62	0.69	0.72	0.69	0.29	0.27	0.59	0.41	0.58	0.44		0.62	0.24
Total Current Assets	0.85	0.4	0.33	0.85	0.88	0.64	0.2	0.73	0.88	0.79	0.67	0.37	0.88	0.98	0.84	0.42	0.4	0.59	0.47	0.97	0.54	-0.15	0.65	0.62		0.37
Short Term Debt	0.56	0.57	0.23	0.69	0.45	0.54	0.53	0.36	0.5	0.12	0.6	0.3	0.22	0.32	0.53	0.48	0.23	0.33	0.46	0.36	-0.11	-0.1	0.58	0.24	0.37

Click cells to compare fundamentals

ICL Israel Account Relationship Matchups

ICL Israel fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	9.2B	9.7B	11.1B	11.8B	11.5B	7.7B
Short Long Term Debt Total	2.6B	2.8B	3.0B	2.8B	2.7B	2.2B
Other Current Liab	587M	741M	938M	1.0B	844.0M	531.1M
Total Current Liabilities	1.8B	2.2B	2.6B	2.6B	2.6B	1.9B
Total Stockholder Equity	3.9B	3.9B	4.5B	5.5B	5.7B	3.1B
Property Plant And Equipment Net	5.2B	5.6B	5.8B	6.0B	6.3B	3.7B
Net Debt	2.5B	2.6B	2.5B	2.4B	2.2B	2.0B
Retained Earnings	3.9B	3.8B	4.3B	5.4B	5.5B	5.8B
Accounts Payable	712M	735M	1.1B	1.0B	904.5M	633.2M
Cash	95M	214M	473M	417M	416.5M	437.4M
Non Current Assets Total	6.5B	6.8B	7.2B	7.2B	7.5B	4.8B
Non Currrent Assets Other	353M	393M	279.8M	228M	217.9M	228.4M
Cash And Short Term Investments	191M	314M	564M	508M	587.1M	325.4M
Net Receivables	1.2B	1.3B	1.8B	1.9B	1.6B	1.2B
Good Will	302M	320M	502M	507M	525.6M	266.1M
Common Stock Shares Outstanding	1.3B	1.3B	1.3B	1.3B	1.3B	1.4B
Short Term Investments	92M	96M	100M	91M	170.6M	127.4M
Liabilities And Stockholders Equity	9.2B	9.7B	11.1B	11.8B	11.5B	7.7B
Non Current Liabilities Total	3.4B	3.4B	3.7B	3.4B	2.9B	2.6B
Inventory	1.3B	1.3B	1.6B	2.1B	1.7B	1.3B
Other Current Assets	51M	50M	115.2M	4.0B	121.0M	114.9M
Other Stockholder Equity	(62M)	(56M)	(36M)	(27M)	(25.8M)	(24.5M)
Total Liab	5.1B	5.6B	6.3B	6.0B	5.5B	4.5B
Property Plant And Equipment Gross	5.3B	5.6B	12.5B	13.0B	13.8B	14.5B
Total Current Assets	2.7B	2.8B	3.9B	4.5B	4.0B	2.9B
Accumulated Other Comprehensive Income	(439M)	(312M)	(306M)	(443M)	(335.2M)	(352.0M)
Short Term Debt	420M	684M	577M	512M	850.9M	537.1M
Current Deferred Revenue	42M	17M	33M	41M	16.9M	16.0M
Intangible Assets	332M	336M	365M	345M	343M	403.7M
Other Liab	1.2B	1.3B	1.3B	1.1B	1.3B	1.1B
Other Assets	362M	309M	378M	524M	434.7M	384.2M
Long Term Debt	2.2B	2.1B	2.4B	2.3B	1.6B	2.3B
Property Plant Equipment	5.3B	5.6B	5.8B	6.0B	6.9B	5.1B
Net Tangible Assets	3.3B	3.3B	3.7B	4.6B	5.3B	3.1B
Long Term Investments	140M	83M	26M	3M	2M	1.9M
Short Long Term Debt	371M	684M	577M	512M	786M	523.7M
Long Term Debt Total	1.8B	2.2B	2.1B	2.4B	2.2B	1.9B

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as ICL Israel Chemicals using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

When determining whether ICL Israel Chemicals is a strong investment it is important to analyze ICL Israel's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ICL Israel's future performance. For an informed investment choice regarding ICL Stock, refer to the following important reports:

How To Invest In ICL

Details

Is ICL Stock a good investment?

Details

What is ICL Israel's Net Worth?

Details

Largest Agricultural Inputs Companies

View

Largest Basic Materials Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

Note that the ICL Israel Chemicals information on this page should be used as a complementary analysis to other ICL Israel's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for ICL Stock analysis

When running ICL Israel's price analysis, check to measure ICL Israel's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICL Israel is operating at the current time. Most of ICL Israel's value examination focuses on studying past and present price action to predict the probability of ICL Israel's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICL Israel's price. Additionally, you may evaluate how the addition of ICL Israel to your portfolios can decrease your overall portfolio volatility.

	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	Transaction History View history of all your transactions and understand their impact on performance
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk

Is ICL Israel's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICL Israel. If investors know ICL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICL Israel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.63)

Dividend Share

0.214

Earnings Share

0.36

Revenue Per Share

5.549

Quarterly Revenue Growth

(0.18)

The market value of ICL Israel Chemicals is measured differently than its book value, which is the value of ICL that is recorded on the company's balance sheet. Investors also form their own opinion of ICL Israel's value that differs from its market value or its book value, called intrinsic value, which is ICL Israel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICL Israel's market value can be influenced by many factors that don't directly affect ICL Israel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between ICL Israel's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICL Israel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICL Israel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

ICL Cash vs Total Current Liabilities Analysis

Cash vs Total Current Liabilities

Cash vs Total Current Liabilities Correlation Analysis

Correlation Coefficient

Cash

Total Current Liabilities

ICL Israel fundamental ratios Correlations

ICL Israel Account Relationship Matchups

High Positive Relationship

High Negative Relationship

ICL Israel fundamental ratios Accounts

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for ICL Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Debt	+ 0.98	Short Long Term Debt Total
Non Current Assets Total	+ 0.98	Property Plant And Equipment Net
Total Current Assets	+ 0.98	Net Receivables
Non Current Liabilities Total	+ 0.97	Short Long Term Debt Total
Total Current Assets	+ 0.97	Inventory
Non Current Assets Total	+ 0.96	Total Assets

Other Stockholder Equity	- 0.52	Non Currrent Assets Other
Other Stockholder Equity	- 0.38	Short Term Investments
Short Term Investments	- 0.25	Other Current Liab
Short Term Investments	- 0.22	Net Debt
Non Currrent Assets Other	- 0.21	Other Current Liab
Cash	- 0.17	Net Debt